It is important to note that at this point studies in the blood indicate that only about 15% of MS patients have detectable antibody to anoctamin 2,3 and about 25% of MS patients have antibody in blood to GlialCAM.2 The gene discussed is ANO2; the disease is myeloid sarcoma.